2023-08-10 from med.ubc.ca
UBC faculty of medicine researchers have been awarded $7 million in new funding to advance precision medicine approaches that promise to transform diabetes treatment.
The funding, from the Canadian Institutes of Health Research in collaboration with JDRF Canada, provides $3.5 million to two UBC-led projects aimed at improving diabetes treatment, care and prevention. Canada is among the ten countries with the highest rates of type 1 diabetes in the world, and while some treatment advancements have been made, the disease continues to pose a burden for patients, families and communities.
In total, the Government of Canada and JDRF Canada announced an investment of $33 million for 12 research projects across the country.
The UBC projects build on decades of world-leading work by faculty of medicine researchers to develop new treatment and prevention strategies for diabetes. In 2021, UBC became home to the first JDRF Centre of Excellence in type 1 diabetes in Canada, one of just five centres worldwide.
Read more here